{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:28:25Z","timestamp":1793640505083,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":239,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02744","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:14:23Z","timestamp":1788448463000},"page":"e02744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Extragenital Mycoplasma hominis infection following obinutuzumab therapy in a patient with chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6942-6766","authenticated-orcid":false,"given":"Katherine","family":"Benandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas S.","family":"Blanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idcr.2026.e02744_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijmmb.2020.10.020","article-title":"Mycoplasma hominis: an under recognized pathogen","volume":"39","author":"Ahmed","year":"2021","journal-title":"Indian J Med Microbiol"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02744_bib2","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.cmi.2018.02.003","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)","volume":"24","author":"Mikulska","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02744_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237798","article-title":"L. Mycoplasma hominis septic arthritis in a patient with hypogammaglobinaemia and rheumatoid arthritis","volume":"14","author":"Bozo","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02744_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s15010-015-0859-6","article-title":"A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity","volume":"44","author":"Nulens","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.idcr.2026.e02744_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01260","article-title":"An enemy in shadows \u2013 Mycoplasma hominis septic arthritis and iliopsoas abscess: case report and review of the literature","volume":"26","author":"Ali","year":"2021","journal-title":"IDCases"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02744_bib6","article-title":"The brief case: Mycoplasma hominis extragenital abscess","volume":"59","author":"Stabler","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"1_suppl","key":"10.1016\/j.idcr.2026.e02744_bib7","doi-asserted-by":"crossref","first-page":"136S","DOI":"10.1177\/01455613221113814","article-title":"Mycoplasma Hominis: a rare case of acute otitis media and facial nerve paralysis","volume":"104","author":"Sadhar","year":"2025","journal-title":"Ear Nose Throat J"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02744_bib8","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s40121-024-01035-9","article-title":"Mycoplasma hominis as cause of extragenital Infection in patients with hypogammaglobulinemia: report of 2 cases and literature review","volume":"13","author":"Russo","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02744_bib9","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/j.ijid.2010.02.2253","article-title":"Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient","volume":"14","author":"MacKenzie","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.idcr.2026.e02744_bib10","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1007\/s10072-025-08329-x","article-title":"Secondary hypogammaglobulinemia and lymphocytopenia in patients with inflammatory neurological diseases on anti-CD20 therapy: risk of infection and infection-related mortality","volume":"46","author":"Karaman","year":"2025","journal-title":"Neurol Sci"},{"key":"10.1016\/j.idcr.2026.e02744_bib11","series-title":"Infectious complications in biologic and targeted therapies","year":"2022"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02744_bib12","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/clinids\/17.Supplement_1.S243","article-title":"Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression","volume":"17","author":"Meyer","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02744_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0002-9343(90)90338-E","article-title":"Extragenital Mycoplasma hominis infections in adults","volume":"89","author":"McMahon","year":"1990","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02744_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ard.53.3.183","article-title":"Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years","volume":"53","author":"Furr","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"9717","key":"10.1016\/j.idcr.2026.e02744_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0140-6736(09)61595-6","article-title":"Bacterial septic arthritis in adults","volume":"375","author":"Mathews","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.idcr.2026.e02744_bib16","author":"Benzon","year":"2025","journal-title":"Reg Anesth Pain Med"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02744_bib17","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/AAC.46.10.3142-3150.2002","article-title":"Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis","volume":"46","author":"Pereyre","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02744_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0732-8893(02)00459-5","article-title":"In vitro susceptibility of Mycoplasma hominis clinical isolates to tetracyclines, quinolones and macrolides","volume":"44","author":"Samra","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02744_bib19","first-page":"256","article-title":"Evaluation of culture media for the recovery of Mycoplasma hominis from the human urogenital tract","volume":"10","author":"Tully","year":"1983","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02744_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/jcm.21.3.298-301.1985","article-title":"Detection of Mycoplasma hominis septicemia by radiometric blood culture","volume":"21","author":"Smaron","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02744_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13822","article-title":"Mycoplasma hominis infections in solid organ transplant recipients: clinical characteristics, treatment outcomes, and comparison of phenotypic and genotypic susceptibility profiles","volume":"24","author":"Chang","year":"2022","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1016\/j.idcr.2026.e02744_bib22","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1128\/JCM.39.12.4328-4331.2001","article-title":"Evaluation of BacT\/ALERT system for detection of Mycoplasma hominis in simulated blood cultures","volume":"39","author":"Waites","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02744_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10156-012-0527-z","article-title":"Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years","volume":"19","author":"De Francesco","year":"2013","journal-title":"J Infect Chemother"},{"issue":"11","key":"10.1016\/j.idcr.2026.e02744_bib24","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1469-0691.2010.03155.x","article-title":"In-vitro activities of tetracyclines, macrolides, fluoroquinolones and 198 clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 199 years","volume":"16","author":"Krausse","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02744_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/40.5.622","article-title":"Antibiotic susceptibilities of mycoplasmas and treatment of 201 mycoplasmal infections","volume":"40","author":"Taylor-Robinson","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2026.e02744_bib26","article-title":"Clinical characteristics and antimicrobial management of invasive Mycoplasma hominis infection: a case report and literature review","volume":"13","author":"Liu","year":"2026","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.idcr.2026.e02744_bib27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jiac.2016.04.008","article-title":"Mycoplasma hominis vertebral spine infection: Case report and a review of infections of bone and joints","volume":"22","author":"Tyner","year":"2016","journal-title":"J Infect Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02744_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00264-019-04451-6","article-title":"Diagnosis and treatment of mycoplasmal septic arthritis: a systematic review","volume":"44","author":"Chen","year":"2020","journal-title":"Int Orthop"},{"issue":"12","key":"10.1016\/j.idcr.2026.e02744_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2013.04.027","article-title":"Systematic PCR detection in culture-negative osteoarticular infections","volume":"126","author":"Levy","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.idcr.2026.e02744_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae104","article-title":"Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Miller","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092600257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092600257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:56:58Z","timestamp":1793638618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092600257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":30,"alternative-id":["S221425092600257X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02744","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extragenital Mycoplasma hominis infection following obinutuzumab therapy in a patient with chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02744"}}